Safety, immunogenicity and protection of heterologous boost with an aerosolised Ad5-nCoV after two-dose inactivated COVID-19 vaccines in adults: a multicentre, open-label phase 3 trial

Jingxin Li, Lihua Hou, Jin-Bo Gou, Zundong Yin, Shipo Wu, Fuzhen Wang, Zhe Zhang, Zhihang Peng, Tao Zhu, Hongbing Shen,

The Lancet Infectious Diseases · 2023 · 54 citations · 17 references

DOIFull text

Open access

Concepts

References

17